Our mission

Improve the clinical outcome for Quebec cancer patients
by developing and offering novel therapeutic options.

Last news

Les résultats de 2 études déterminantes et portant sur les environnements immunitaires des tumeurs pulmonaires et cérébrales ont été publiés
@Nature Ces travaux ont été réalisés sous la direction de nos membres @loganawalsh
@DanielaQuail et Peter Siegel http://bit.ly/3Zi9CbG

Two seminal studies investigating immune landscapes of lung and brain tumours were published @Nature This work was led by @QConsortium members @loganawalsh @DanielaQuail & Peter Siegel
Read the papers ➡️
🫁 Lung http://tinyurl.com/3jak565z
🧠 Brain http://tinyurl.com/ykvu6sux

Logan Walsh @loganawalsh

What could be better than publishing a paper in @Nature? Publishing 2! 🥳 🥂 🙌
Couldn’t be prouder of our team today 🥹
My first tweetorial:

La plateforme ATiM recherche un(e) candidat(e) motivé(e) pour répondre aux besoins des #biobanques du @QConsortium, @LDI_ILD, @RIMUHC1, @CRCHUM, @VitaliteNB, @MarathonOfHope...
https://www.chumontreal.qc.ca/emplois/analyste-informatique-specialisee-recherche-biomedicale-phpmysql
#OffreEmploi #biobanking #biorepository #TFRI #biospecimen #ATiM

Grateful to AMAZING co-corresponding authors @PJoubertPatho Peter Siegel & (on both studies) TME aficionado @danielaquail - & collaborators Marie-Christine Guiot, Kevin Petrecca, @LeilaAkkari1 @DoctorJSpicer @pierrefiset @IanWatsonLab @Parklabmcgillu & many more not on twitter 🙏

Load More...

Our members